Cargando…
Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
BACKGROUND: The long term and complex nature of Chagas disease in humans has restricted studies on vaccine feasibility. Animal models also have limitations due to technical difficulties in monitoring the extremely low parasite burden that is characteristic of chronic stage infections. Advances in im...
Autores principales: | Mann, Gurdip Singh, Francisco, Amanda F., Jayawardhana, Shiromani, Taylor, Martin C., Lewis, Michael D., Olmo, Francisco, de Freitas, Elisangela Oliveira, Leoratti, Fabiana M. S., López-Camacho, Cesar, Reyes-Sandoval, Arturo, Kelly, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190179/ https://www.ncbi.nlm.nih.gov/pubmed/32302312 http://dx.doi.org/10.1371/journal.pntd.0007717 |
Ejemplares similares
-
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging
por: Francisco, Amanda Fortes, et al.
Publicado: (2015) -
Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
por: Taylor, Martin C., et al.
Publicado: (2020) -
Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
por: Jayawardhana, Shiromani, et al.
Publicado: (2023) -
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
por: Lewis, Michael D., et al.
Publicado: (2016) -
Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
por: Francisco, Amanda Fortes, et al.
Publicado: (2016)